Overview

Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis

Status:
Unknown status

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether PR022 Topical Gels are safe and effective treatments for mild-to-moderate atopic dermatitis (AD).

Phase:

Phase 2

Details

Lead Sponsor:

Realm Therapeutics, Inc.